Latest Market Impact News

Almonty Industries is set to join the prestigious Russell 1000 and 3000 indexes in June 2026, marking a significant milestone that highlights its growth and operational progress amid rising tungsten demand.

Delorean Corporation has closed its Share Purchase Plan, raising $750,000 through the issue of over 8.3 million shares at $0.09 each, supplementing earlier strategic funding from LMS Energy.

Vectus Biosystems has secured $791,000 through a placement to accelerate its lead fibrosis drug VB0004's Phase IB clinical trial and advance other drug candidates.

Vmoto Limited disclosed it held only one formal board meeting in FY25, relying heavily on circular resolutions, and outlined plans to increase meeting frequency in 2026. The company clarified its trade insurance arrangements and affirmed director independence amid ASX queries.

Argenica Therapeutics has passed a critical FDA genotoxicity test for its stroke drug ARG-007, advancing its IND application and edging closer to Phase 2b clinical trials in the US and Australia.

The Australian Taxation Office has issued a Class Ruling confirming scrip for scrip capital gains tax roll-over relief for Diversified United Investment shareholders following their merger with Australian United Investment Company.

Electro Optic Systems (ASX:EOS) has raised A$190 million through institutional and strategic placements at an 9.3% discount, alongside a planned A$25 million share purchase plan, to fund its MARSS acquisition and expand defence capabilities.

Comet Ridge has voluntarily suspended trading of its shares on the ASX pending an update on its acquisition of Santos’ stake in the Mahalo Gas Project. The suspension aims to prevent uninformed trading while discussions continue, with an announcement expected before markets reopen on 21 May 2026.

AoFrio Limited has secured NZ$4.56 million through a share placement to existing investor Wairahi Investments, underpinning a bold strategy to boost revenue growth to 25% annually. A follow-up rights issue will allow current shareholders to participate at the same price.

Complii FinTech Solutions has landed a strategic two-year deal with a major financial institution, marking its entry into the institutional market segment and positioning the company for scalable growth in capital raising software services.

Ballymore Resources launches a $3.24 million pro-rata entitlement offer priced at 12.5 cents per share, sweetened with free attaching options exercisable at 22 cents, to fund ongoing Queensland exploration and development.

Diablo Resources has completed the first tranche of a placement, raising $764,400 through 58.8 million shares at 1.3 cents each, with a shareholder meeting planned in June to approve a further $2.7 million raise.